Fintel on MSN1d
Jefferies Upgrades Cardinal Health (CAH)Fintel reports that on February 5, 2025, Jefferies upgraded their outlook for Cardinal Health (NYSE:CAH) from Hold to Buy.
Jefferies has upgraded Cardinal Health (CAH) to buy from hold, citing management's emerging EPS track record. Read more here.
Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...
Bank of America Securities analyst Allen Lutz maintained a Buy rating on Cardinal Health (CAH – Research Report) today. The company’s shares ...
Cardinal Health Inc. closed 5.65% below its 52-week high of $132.84, which the company achieved on January 30th.
StockStory.org on MSN6d
Cardinal Health (NYSE:CAH) Beats Q4 Sales TargetsHealthcare distributor and services company Cardinal Health (NYSE:CAH) in Q4 CY2024, but sales fell by 3.8% year on year to ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
With a positive outlook, McKesson raised its fiscal 2025 adjusted EPS guidance to a range of $32.55 to $32.95, indicating ...
Pre-Market: 5:36:21 a.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback